Review



anti cd105 fitc  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    R&D Systems anti cd105 fitc
    Anti Cd105 Fitc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 456 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd105-fitc/FITC+Antibody/10__3390_slash_ijms262010017-179-30-31
    Average 95 stars, based on 456 article reviews
    anti cd105 fitc - by Bioz Stars, 2026-09
    95/100 stars

    Images

    Related Articles

    Incubation:

    Article Title: Interleukin-1β-induced matrix metalloproteinase-3 via ERK1/2 pathway to promote mesenchymal stem cell migration
    Article Snippet: Cell were then suspended 1*10 6 cells in 100 μl PBS and incubated with 1:20 dilution of conjugated antibodies CD105-FITC (R&D systems, USA), CD34-FITC (Becton, Dickinson and Company, USA), CD73-PE (Becton, Dickinson and Company, USA), CD45-PE (Thermo Fisher Scientific, USA), CD90-PE (Beckman Coulter, USA) at 4°C for 30minutes on the shaker.

    Article Title: Trophic and immunomodulatory effects of adipose tissue derived stem cells in a preclinical murine model of endometriosis
    Article Snippet: They were then incubated for 30 min at 25 °C with CD105-FITC, CD29-PE, Sca-1-APC, and CD45-PerCP (all from the Mouse Mesenchymal Stem Cell [MSC] Multi-Color Flow Kit, cat. no. FMC003; R&D Systems).

    Article Title: Dental pulp pluripotent-like stem cells (DPPSC), a new stem cell population with chromosomal stability and osteogenic capacity for biomaterials evaluation
    Article Snippet: The following fluorochrome labelled monoclonal antibodies were used: CD105-FITC (R&D Systems), CD29-PE (R&D Systems), CD146-FITC (BD Pharmingen), CD45-PE (BD Pharmingen), NANOG-FITC and OCT3/4-FITC (R&D Systems).

    Article Title: Deletion of RBPJK in Mesenchymal Stem Cells Enhances Osteogenic Activity by Up-Regulation of BMP Signaling.
    Article Snippet: Flow cytometry analysis MSC phenotype was evaluated after 2 weeks’ expansion by the expression of CD34-APC (BD Biosciences Pharmingen, San Diego, CA), CD45-FITC (BD Biosciences Pharmingen, San Diego, CA), CD90–PE (Dako Cytomation Denmark A/S, Glostrup, Denmark), CD73-PE (BD Biosciences Pharmingen) and CD105-FITC (RD Systems, Minneapolis, MN).

    Article Title: Overexpression of MiR-183/96/182 Triggers Retina-Like Fate in Human Bone Marrow-Derived Mesenchymal Stem Cells (hBMSCs) in Culture
    Article Snippet: Briefly, the cells were dissociated with trypsin/EDTA; then, cell suspensions were stained using various antibodies against MSC markers including CD105-FITC (R&D Systems), CD90-PE (Dako), CD73-PE (Abcam), CD45-FITC (Dako), and CD34-PE (Biosciences) and secondary goat antimouse IgG-PE.

    Article Title: Oleate Abrogates Palmitate-Induced Lipotoxicity and Proinflammatory Response in Human Bone Marrow-Derived Mesenchymal Stem Cells and Osteoblastic Cells.
    Article Snippet: Cells were stained with the following antibodies: CD34-PE, CD45-FITC and CD73-PE from BD Biosciences (San Jose, USA), CD90-APC, CD105-FITC, and ALP-APC from R&D Systems (Abingdon, United Kingdom) (34).

    Article Title: Autologous Matrix-Induced Chondrogenesis (AMIC) and AMIC Enhanced by Autologous Concentrated Bone Marrow Aspirate (BMAC) Allow for Stable Clinical and Functional Improvements at up to 9 Years Follow-Up: Results from a Randomized Controlled Study
    Article Snippet: The immunophenotype of cells cultured for two passages in human mesenchymal stem cells growth medium (MSCGM–Lonza, Verviers, Belgium) was analyzed by FACSCaliburTM (Becton-Dickinson, Franklin Lakes, NJ, USA) and CellQuestTM analysis software, after staining with the following conjugated antibodies: anti human CD45-PE, CD34-PE, CD31-PE, CD90-PE, CD73-PE, CD166-PE, CD44-PE (all from Becton Dickinson), and CD105-FITC (R&D System, Minneapolis, MN, USA).

    Article Title: Effect of inflammatory environment on equine bone marrow derived mesenchymal stem cells immunogenicity and immunomodulatory properties.
    Article Snippet: Mesenchymal stem cells (MSCs) are being investigated for the treatment of equine joint diseases because of their regenerative potential.. Recently, the focus mainly has addressed to their immunomodulatory capacities.. Inflammation plays a central role in joint pathologies, since the release of proinflammatory mediators to the synovial fluid (SF) leads to the activation of enzymatic degradation of the cartilage.

    Flow Cytometry:

    Article Title: Interleukin-1β-induced matrix metalloproteinase-3 via ERK1/2 pathway to promote mesenchymal stem cell migration
    Article Snippet: Cell were then suspended 1*10 6 cells in 100 μl PBS and incubated with 1:20 dilution of conjugated antibodies CD105-FITC (R&D systems, USA), CD34-FITC (Becton, Dickinson and Company, USA), CD73-PE (Becton, Dickinson and Company, USA), CD45-PE (Thermo Fisher Scientific, USA), CD90-PE (Beckman Coulter, USA) at 4°C for 30minutes on the shaker.

    Article Title: Trophic and immunomodulatory effects of adipose tissue derived stem cells in a preclinical murine model of endometriosis
    Article Snippet: They were then incubated for 30 min at 25 °C with CD105-FITC, CD29-PE, Sca-1-APC, and CD45-PerCP (all from the Mouse Mesenchymal Stem Cell [MSC] Multi-Color Flow Kit, cat. no. FMC003; R&D Systems).

    Article Title: Dental pulp pluripotent-like stem cells (DPPSC), a new stem cell population with chromosomal stability and osteogenic capacity for biomaterials evaluation
    Article Snippet: The following fluorochrome labelled monoclonal antibodies were used: CD105-FITC (R&D Systems), CD29-PE (R&D Systems), CD146-FITC (BD Pharmingen), CD45-PE (BD Pharmingen), NANOG-FITC and OCT3/4-FITC (R&D Systems).

    Article Title: Deletion of RBPJK in Mesenchymal Stem Cells Enhances Osteogenic Activity by Up-Regulation of BMP Signaling.
    Article Snippet: Flow cytometry analysis MSC phenotype was evaluated after 2 weeks’ expansion by the expression of CD34-APC (BD Biosciences Pharmingen, San Diego, CA), CD45-FITC (BD Biosciences Pharmingen, San Diego, CA), CD90–PE (Dako Cytomation Denmark A/S, Glostrup, Denmark), CD73-PE (BD Biosciences Pharmingen) and CD105-FITC (RD Systems, Minneapolis, MN).

    Article Title: Overexpression of MiR-183/96/182 Triggers Retina-Like Fate in Human Bone Marrow-Derived Mesenchymal Stem Cells (hBMSCs) in Culture
    Article Snippet: Briefly, the cells were dissociated with trypsin/EDTA; then, cell suspensions were stained using various antibodies against MSC markers including CD105-FITC (R&D Systems), CD90-PE (Dako), CD73-PE (Abcam), CD45-FITC (Dako), and CD34-PE (Biosciences) and secondary goat antimouse IgG-PE.

    Article Title: Oleate Abrogates Palmitate-Induced Lipotoxicity and Proinflammatory Response in Human Bone Marrow-Derived Mesenchymal Stem Cells and Osteoblastic Cells.
    Article Snippet: Cells were stained with the following antibodies: CD34-PE, CD45-FITC and CD73-PE from BD Biosciences (San Jose, USA), CD90-APC, CD105-FITC, and ALP-APC from R&D Systems (Abingdon, United Kingdom) (34).

    Article Title: Autologous Matrix-Induced Chondrogenesis (AMIC) and AMIC Enhanced by Autologous Concentrated Bone Marrow Aspirate (BMAC) Allow for Stable Clinical and Functional Improvements at up to 9 Years Follow-Up: Results from a Randomized Controlled Study
    Article Snippet: The immunophenotype of cells cultured for two passages in human mesenchymal stem cells growth medium (MSCGM–Lonza, Verviers, Belgium) was analyzed by FACSCaliburTM (Becton-Dickinson, Franklin Lakes, NJ, USA) and CellQuestTM analysis software, after staining with the following conjugated antibodies: anti human CD45-PE, CD34-PE, CD31-PE, CD90-PE, CD73-PE, CD166-PE, CD44-PE (all from Becton Dickinson), and CD105-FITC (R&D System, Minneapolis, MN, USA).

    Article Title: Effect of inflammatory environment on equine bone marrow derived mesenchymal stem cells immunogenicity and immunomodulatory properties.
    Article Snippet: Mesenchymal stem cells (MSCs) are being investigated for the treatment of equine joint diseases because of their regenerative potential.. Recently, the focus mainly has addressed to their immunomodulatory capacities.. Inflammation plays a central role in joint pathologies, since the release of proinflammatory mediators to the synovial fluid (SF) leads to the activation of enzymatic degradation of the cartilage.

    Staining:

    Article Title: Interleukin-1β-induced matrix metalloproteinase-3 via ERK1/2 pathway to promote mesenchymal stem cell migration
    Article Snippet: Cell were then suspended 1*10 6 cells in 100 μl PBS and incubated with 1:20 dilution of conjugated antibodies CD105-FITC (R&D systems, USA), CD34-FITC (Becton, Dickinson and Company, USA), CD73-PE (Becton, Dickinson and Company, USA), CD45-PE (Thermo Fisher Scientific, USA), CD90-PE (Beckman Coulter, USA) at 4°C for 30minutes on the shaker.

    Article Title: Trophic and immunomodulatory effects of adipose tissue derived stem cells in a preclinical murine model of endometriosis
    Article Snippet: They were then incubated for 30 min at 25 °C with CD105-FITC, CD29-PE, Sca-1-APC, and CD45-PerCP (all from the Mouse Mesenchymal Stem Cell [MSC] Multi-Color Flow Kit, cat. no. FMC003; R&D Systems).

    Article Title: Dental pulp pluripotent-like stem cells (DPPSC), a new stem cell population with chromosomal stability and osteogenic capacity for biomaterials evaluation
    Article Snippet: The following fluorochrome labelled monoclonal antibodies were used: CD105-FITC (R&D Systems), CD29-PE (R&D Systems), CD146-FITC (BD Pharmingen), CD45-PE (BD Pharmingen), NANOG-FITC and OCT3/4-FITC (R&D Systems).

    Article Title: Deletion of RBPJK in Mesenchymal Stem Cells Enhances Osteogenic Activity by Up-Regulation of BMP Signaling.
    Article Snippet: Flow cytometry analysis MSC phenotype was evaluated after 2 weeks’ expansion by the expression of CD34-APC (BD Biosciences Pharmingen, San Diego, CA), CD45-FITC (BD Biosciences Pharmingen, San Diego, CA), CD90–PE (Dako Cytomation Denmark A/S, Glostrup, Denmark), CD73-PE (BD Biosciences Pharmingen) and CD105-FITC (RD Systems, Minneapolis, MN).

    Article Title: Overexpression of MiR-183/96/182 Triggers Retina-Like Fate in Human Bone Marrow-Derived Mesenchymal Stem Cells (hBMSCs) in Culture
    Article Snippet: Briefly, the cells were dissociated with trypsin/EDTA; then, cell suspensions were stained using various antibodies against MSC markers including CD105-FITC (R&D Systems), CD90-PE (Dako), CD73-PE (Abcam), CD45-FITC (Dako), and CD34-PE (Biosciences) and secondary goat antimouse IgG-PE.

    Article Title: Oleate Abrogates Palmitate-Induced Lipotoxicity and Proinflammatory Response in Human Bone Marrow-Derived Mesenchymal Stem Cells and Osteoblastic Cells.
    Article Snippet: Cells were stained with the following antibodies: CD34-PE, CD45-FITC and CD73-PE from BD Biosciences (San Jose, USA), CD90-APC, CD105-FITC, and ALP-APC from R&D Systems (Abingdon, United Kingdom) (34).

    Article Title: Autologous Matrix-Induced Chondrogenesis (AMIC) and AMIC Enhanced by Autologous Concentrated Bone Marrow Aspirate (BMAC) Allow for Stable Clinical and Functional Improvements at up to 9 Years Follow-Up: Results from a Randomized Controlled Study
    Article Snippet: The immunophenotype of cells cultured for two passages in human mesenchymal stem cells growth medium (MSCGM–Lonza, Verviers, Belgium) was analyzed by FACSCaliburTM (Becton-Dickinson, Franklin Lakes, NJ, USA) and CellQuestTM analysis software, after staining with the following conjugated antibodies: anti human CD45-PE, CD34-PE, CD31-PE, CD90-PE, CD73-PE, CD166-PE, CD44-PE (all from Becton Dickinson), and CD105-FITC (R&D System, Minneapolis, MN, USA).

    Article Title: Effect of inflammatory environment on equine bone marrow derived mesenchymal stem cells immunogenicity and immunomodulatory properties.
    Article Snippet: Mesenchymal stem cells (MSCs) are being investigated for the treatment of equine joint diseases because of their regenerative potential.. Recently, the focus mainly has addressed to their immunomodulatory capacities.. Inflammation plays a central role in joint pathologies, since the release of proinflammatory mediators to the synovial fluid (SF) leads to the activation of enzymatic degradation of the cartilage.

    Derivative Assay:

    Article Title: Interleukin-1β-induced matrix metalloproteinase-3 via ERK1/2 pathway to promote mesenchymal stem cell migration
    Article Snippet: Cell were then suspended 1*10 6 cells in 100 μl PBS and incubated with 1:20 dilution of conjugated antibodies CD105-FITC (R&D systems, USA), CD34-FITC (Becton, Dickinson and Company, USA), CD73-PE (Becton, Dickinson and Company, USA), CD45-PE (Thermo Fisher Scientific, USA), CD90-PE (Beckman Coulter, USA) at 4°C for 30minutes on the shaker.

    Article Title: Trophic and immunomodulatory effects of adipose tissue derived stem cells in a preclinical murine model of endometriosis
    Article Snippet: They were then incubated for 30 min at 25 °C with CD105-FITC, CD29-PE, Sca-1-APC, and CD45-PerCP (all from the Mouse Mesenchymal Stem Cell [MSC] Multi-Color Flow Kit, cat. no. FMC003; R&D Systems).

    Article Title: Dental pulp pluripotent-like stem cells (DPPSC), a new stem cell population with chromosomal stability and osteogenic capacity for biomaterials evaluation
    Article Snippet: The following fluorochrome labelled monoclonal antibodies were used: CD105-FITC (R&D Systems), CD29-PE (R&D Systems), CD146-FITC (BD Pharmingen), CD45-PE (BD Pharmingen), NANOG-FITC and OCT3/4-FITC (R&D Systems).

    Article Title: Deletion of RBPJK in Mesenchymal Stem Cells Enhances Osteogenic Activity by Up-Regulation of BMP Signaling.
    Article Snippet: Flow cytometry analysis MSC phenotype was evaluated after 2 weeks’ expansion by the expression of CD34-APC (BD Biosciences Pharmingen, San Diego, CA), CD45-FITC (BD Biosciences Pharmingen, San Diego, CA), CD90–PE (Dako Cytomation Denmark A/S, Glostrup, Denmark), CD73-PE (BD Biosciences Pharmingen) and CD105-FITC (RD Systems, Minneapolis, MN).

    Article Title: Overexpression of MiR-183/96/182 Triggers Retina-Like Fate in Human Bone Marrow-Derived Mesenchymal Stem Cells (hBMSCs) in Culture
    Article Snippet: Briefly, the cells were dissociated with trypsin/EDTA; then, cell suspensions were stained using various antibodies against MSC markers including CD105-FITC (R&D Systems), CD90-PE (Dako), CD73-PE (Abcam), CD45-FITC (Dako), and CD34-PE (Biosciences) and secondary goat antimouse IgG-PE.

    Article Title: Oleate Abrogates Palmitate-Induced Lipotoxicity and Proinflammatory Response in Human Bone Marrow-Derived Mesenchymal Stem Cells and Osteoblastic Cells.
    Article Snippet: Cells were stained with the following antibodies: CD34-PE, CD45-FITC and CD73-PE from BD Biosciences (San Jose, USA), CD90-APC, CD105-FITC, and ALP-APC from R&D Systems (Abingdon, United Kingdom) (34).

    Article Title: Autologous Matrix-Induced Chondrogenesis (AMIC) and AMIC Enhanced by Autologous Concentrated Bone Marrow Aspirate (BMAC) Allow for Stable Clinical and Functional Improvements at up to 9 Years Follow-Up: Results from a Randomized Controlled Study
    Article Snippet: The immunophenotype of cells cultured for two passages in human mesenchymal stem cells growth medium (MSCGM–Lonza, Verviers, Belgium) was analyzed by FACSCaliburTM (Becton-Dickinson, Franklin Lakes, NJ, USA) and CellQuestTM analysis software, after staining with the following conjugated antibodies: anti human CD45-PE, CD34-PE, CD31-PE, CD90-PE, CD73-PE, CD166-PE, CD44-PE (all from Becton Dickinson), and CD105-FITC (R&D System, Minneapolis, MN, USA).

    Article Title: Effect of inflammatory environment on equine bone marrow derived mesenchymal stem cells immunogenicity and immunomodulatory properties.
    Article Snippet: Mesenchymal stem cells (MSCs) are being investigated for the treatment of equine joint diseases because of their regenerative potential.. Recently, the focus mainly has addressed to their immunomodulatory capacities.. Inflammation plays a central role in joint pathologies, since the release of proinflammatory mediators to the synovial fluid (SF) leads to the activation of enzymatic degradation of the cartilage.

    Expressing:

    Article Title: Interleukin-1β-induced matrix metalloproteinase-3 via ERK1/2 pathway to promote mesenchymal stem cell migration
    Article Snippet: Cell were then suspended 1*10 6 cells in 100 μl PBS and incubated with 1:20 dilution of conjugated antibodies CD105-FITC (R&D systems, USA), CD34-FITC (Becton, Dickinson and Company, USA), CD73-PE (Becton, Dickinson and Company, USA), CD45-PE (Thermo Fisher Scientific, USA), CD90-PE (Beckman Coulter, USA) at 4°C for 30minutes on the shaker.

    Article Title: Trophic and immunomodulatory effects of adipose tissue derived stem cells in a preclinical murine model of endometriosis
    Article Snippet: They were then incubated for 30 min at 25 °C with CD105-FITC, CD29-PE, Sca-1-APC, and CD45-PerCP (all from the Mouse Mesenchymal Stem Cell [MSC] Multi-Color Flow Kit, cat. no. FMC003; R&D Systems).

    Article Title: Dental pulp pluripotent-like stem cells (DPPSC), a new stem cell population with chromosomal stability and osteogenic capacity for biomaterials evaluation
    Article Snippet: The following fluorochrome labelled monoclonal antibodies were used: CD105-FITC (R&D Systems), CD29-PE (R&D Systems), CD146-FITC (BD Pharmingen), CD45-PE (BD Pharmingen), NANOG-FITC and OCT3/4-FITC (R&D Systems).

    Article Title: Deletion of RBPJK in Mesenchymal Stem Cells Enhances Osteogenic Activity by Up-Regulation of BMP Signaling.
    Article Snippet: Flow cytometry analysis MSC phenotype was evaluated after 2 weeks’ expansion by the expression of CD34-APC (BD Biosciences Pharmingen, San Diego, CA), CD45-FITC (BD Biosciences Pharmingen, San Diego, CA), CD90–PE (Dako Cytomation Denmark A/S, Glostrup, Denmark), CD73-PE (BD Biosciences Pharmingen) and CD105-FITC (RD Systems, Minneapolis, MN).

    Article Title: Overexpression of MiR-183/96/182 Triggers Retina-Like Fate in Human Bone Marrow-Derived Mesenchymal Stem Cells (hBMSCs) in Culture
    Article Snippet: Briefly, the cells were dissociated with trypsin/EDTA; then, cell suspensions were stained using various antibodies against MSC markers including CD105-FITC (R&D Systems), CD90-PE (Dako), CD73-PE (Abcam), CD45-FITC (Dako), and CD34-PE (Biosciences) and secondary goat antimouse IgG-PE.

    Article Title: Oleate Abrogates Palmitate-Induced Lipotoxicity and Proinflammatory Response in Human Bone Marrow-Derived Mesenchymal Stem Cells and Osteoblastic Cells.
    Article Snippet: Cells were stained with the following antibodies: CD34-PE, CD45-FITC and CD73-PE from BD Biosciences (San Jose, USA), CD90-APC, CD105-FITC, and ALP-APC from R&D Systems (Abingdon, United Kingdom) (34).

    Article Title: Autologous Matrix-Induced Chondrogenesis (AMIC) and AMIC Enhanced by Autologous Concentrated Bone Marrow Aspirate (BMAC) Allow for Stable Clinical and Functional Improvements at up to 9 Years Follow-Up: Results from a Randomized Controlled Study
    Article Snippet: The immunophenotype of cells cultured for two passages in human mesenchymal stem cells growth medium (MSCGM–Lonza, Verviers, Belgium) was analyzed by FACSCaliburTM (Becton-Dickinson, Franklin Lakes, NJ, USA) and CellQuestTM analysis software, after staining with the following conjugated antibodies: anti human CD45-PE, CD34-PE, CD31-PE, CD90-PE, CD73-PE, CD166-PE, CD44-PE (all from Becton Dickinson), and CD105-FITC (R&D System, Minneapolis, MN, USA).

    Article Title: Effect of inflammatory environment on equine bone marrow derived mesenchymal stem cells immunogenicity and immunomodulatory properties.
    Article Snippet: Mesenchymal stem cells (MSCs) are being investigated for the treatment of equine joint diseases because of their regenerative potential.. Recently, the focus mainly has addressed to their immunomodulatory capacities.. Inflammation plays a central role in joint pathologies, since the release of proinflammatory mediators to the synovial fluid (SF) leads to the activation of enzymatic degradation of the cartilage.

    Cell Culture:

    Article Title: Interleukin-1β-induced matrix metalloproteinase-3 via ERK1/2 pathway to promote mesenchymal stem cell migration
    Article Snippet: Cell were then suspended 1*10 6 cells in 100 μl PBS and incubated with 1:20 dilution of conjugated antibodies CD105-FITC (R&D systems, USA), CD34-FITC (Becton, Dickinson and Company, USA), CD73-PE (Becton, Dickinson and Company, USA), CD45-PE (Thermo Fisher Scientific, USA), CD90-PE (Beckman Coulter, USA) at 4°C for 30minutes on the shaker.

    Article Title: Trophic and immunomodulatory effects of adipose tissue derived stem cells in a preclinical murine model of endometriosis
    Article Snippet: They were then incubated for 30 min at 25 °C with CD105-FITC, CD29-PE, Sca-1-APC, and CD45-PerCP (all from the Mouse Mesenchymal Stem Cell [MSC] Multi-Color Flow Kit, cat. no. FMC003; R&D Systems).

    Article Title: Dental pulp pluripotent-like stem cells (DPPSC), a new stem cell population with chromosomal stability and osteogenic capacity for biomaterials evaluation
    Article Snippet: The following fluorochrome labelled monoclonal antibodies were used: CD105-FITC (R&D Systems), CD29-PE (R&D Systems), CD146-FITC (BD Pharmingen), CD45-PE (BD Pharmingen), NANOG-FITC and OCT3/4-FITC (R&D Systems).

    Article Title: Deletion of RBPJK in Mesenchymal Stem Cells Enhances Osteogenic Activity by Up-Regulation of BMP Signaling.
    Article Snippet: Flow cytometry analysis MSC phenotype was evaluated after 2 weeks’ expansion by the expression of CD34-APC (BD Biosciences Pharmingen, San Diego, CA), CD45-FITC (BD Biosciences Pharmingen, San Diego, CA), CD90–PE (Dako Cytomation Denmark A/S, Glostrup, Denmark), CD73-PE (BD Biosciences Pharmingen) and CD105-FITC (RD Systems, Minneapolis, MN).

    Article Title: Overexpression of MiR-183/96/182 Triggers Retina-Like Fate in Human Bone Marrow-Derived Mesenchymal Stem Cells (hBMSCs) in Culture
    Article Snippet: Briefly, the cells were dissociated with trypsin/EDTA; then, cell suspensions were stained using various antibodies against MSC markers including CD105-FITC (R&D Systems), CD90-PE (Dako), CD73-PE (Abcam), CD45-FITC (Dako), and CD34-PE (Biosciences) and secondary goat antimouse IgG-PE.

    Article Title: Oleate Abrogates Palmitate-Induced Lipotoxicity and Proinflammatory Response in Human Bone Marrow-Derived Mesenchymal Stem Cells and Osteoblastic Cells.
    Article Snippet: Cells were stained with the following antibodies: CD34-PE, CD45-FITC and CD73-PE from BD Biosciences (San Jose, USA), CD90-APC, CD105-FITC, and ALP-APC from R&D Systems (Abingdon, United Kingdom) (34).

    Article Title: Autologous Matrix-Induced Chondrogenesis (AMIC) and AMIC Enhanced by Autologous Concentrated Bone Marrow Aspirate (BMAC) Allow for Stable Clinical and Functional Improvements at up to 9 Years Follow-Up: Results from a Randomized Controlled Study
    Article Snippet: The immunophenotype of cells cultured for two passages in human mesenchymal stem cells growth medium (MSCGM–Lonza, Verviers, Belgium) was analyzed by FACSCaliburTM (Becton-Dickinson, Franklin Lakes, NJ, USA) and CellQuestTM analysis software, after staining with the following conjugated antibodies: anti human CD45-PE, CD34-PE, CD31-PE, CD90-PE, CD73-PE, CD166-PE, CD44-PE (all from Becton Dickinson), and CD105-FITC (R&D System, Minneapolis, MN, USA).

    Article Title: Effect of inflammatory environment on equine bone marrow derived mesenchymal stem cells immunogenicity and immunomodulatory properties.
    Article Snippet: Mesenchymal stem cells (MSCs) are being investigated for the treatment of equine joint diseases because of their regenerative potential.. Recently, the focus mainly has addressed to their immunomodulatory capacities.. Inflammation plays a central role in joint pathologies, since the release of proinflammatory mediators to the synovial fluid (SF) leads to the activation of enzymatic degradation of the cartilage.

    Software:

    Article Title: Interleukin-1β-induced matrix metalloproteinase-3 via ERK1/2 pathway to promote mesenchymal stem cell migration
    Article Snippet: Cell were then suspended 1*10 6 cells in 100 μl PBS and incubated with 1:20 dilution of conjugated antibodies CD105-FITC (R&D systems, USA), CD34-FITC (Becton, Dickinson and Company, USA), CD73-PE (Becton, Dickinson and Company, USA), CD45-PE (Thermo Fisher Scientific, USA), CD90-PE (Beckman Coulter, USA) at 4°C for 30minutes on the shaker.

    Article Title: Trophic and immunomodulatory effects of adipose tissue derived stem cells in a preclinical murine model of endometriosis
    Article Snippet: They were then incubated for 30 min at 25 °C with CD105-FITC, CD29-PE, Sca-1-APC, and CD45-PerCP (all from the Mouse Mesenchymal Stem Cell [MSC] Multi-Color Flow Kit, cat. no. FMC003; R&D Systems).

    Article Title: Dental pulp pluripotent-like stem cells (DPPSC), a new stem cell population with chromosomal stability and osteogenic capacity for biomaterials evaluation
    Article Snippet: The following fluorochrome labelled monoclonal antibodies were used: CD105-FITC (R&D Systems), CD29-PE (R&D Systems), CD146-FITC (BD Pharmingen), CD45-PE (BD Pharmingen), NANOG-FITC and OCT3/4-FITC (R&D Systems).

    Article Title: Deletion of RBPJK in Mesenchymal Stem Cells Enhances Osteogenic Activity by Up-Regulation of BMP Signaling.
    Article Snippet: Flow cytometry analysis MSC phenotype was evaluated after 2 weeks’ expansion by the expression of CD34-APC (BD Biosciences Pharmingen, San Diego, CA), CD45-FITC (BD Biosciences Pharmingen, San Diego, CA), CD90–PE (Dako Cytomation Denmark A/S, Glostrup, Denmark), CD73-PE (BD Biosciences Pharmingen) and CD105-FITC (RD Systems, Minneapolis, MN).

    Article Title: Overexpression of MiR-183/96/182 Triggers Retina-Like Fate in Human Bone Marrow-Derived Mesenchymal Stem Cells (hBMSCs) in Culture
    Article Snippet: Briefly, the cells were dissociated with trypsin/EDTA; then, cell suspensions were stained using various antibodies against MSC markers including CD105-FITC (R&D Systems), CD90-PE (Dako), CD73-PE (Abcam), CD45-FITC (Dako), and CD34-PE (Biosciences) and secondary goat antimouse IgG-PE.

    Article Title: Oleate Abrogates Palmitate-Induced Lipotoxicity and Proinflammatory Response in Human Bone Marrow-Derived Mesenchymal Stem Cells and Osteoblastic Cells.
    Article Snippet: Cells were stained with the following antibodies: CD34-PE, CD45-FITC and CD73-PE from BD Biosciences (San Jose, USA), CD90-APC, CD105-FITC, and ALP-APC from R&D Systems (Abingdon, United Kingdom) (34).

    Article Title: Autologous Matrix-Induced Chondrogenesis (AMIC) and AMIC Enhanced by Autologous Concentrated Bone Marrow Aspirate (BMAC) Allow for Stable Clinical and Functional Improvements at up to 9 Years Follow-Up: Results from a Randomized Controlled Study
    Article Snippet: The immunophenotype of cells cultured for two passages in human mesenchymal stem cells growth medium (MSCGM–Lonza, Verviers, Belgium) was analyzed by FACSCaliburTM (Becton-Dickinson, Franklin Lakes, NJ, USA) and CellQuestTM analysis software, after staining with the following conjugated antibodies: anti human CD45-PE, CD34-PE, CD31-PE, CD90-PE, CD73-PE, CD166-PE, CD44-PE (all from Becton Dickinson), and CD105-FITC (R&D System, Minneapolis, MN, USA).

    Article Title: Effect of inflammatory environment on equine bone marrow derived mesenchymal stem cells immunogenicity and immunomodulatory properties.
    Article Snippet: Mesenchymal stem cells (MSCs) are being investigated for the treatment of equine joint diseases because of their regenerative potential.. Recently, the focus mainly has addressed to their immunomodulatory capacities.. Inflammation plays a central role in joint pathologies, since the release of proinflammatory mediators to the synovial fluid (SF) leads to the activation of enzymatic degradation of the cartilage.

    Fluorescence:

    Article Title: Interleukin-1β-induced matrix metalloproteinase-3 via ERK1/2 pathway to promote mesenchymal stem cell migration
    Article Snippet: Cell were then suspended 1*10 6 cells in 100 μl PBS and incubated with 1:20 dilution of conjugated antibodies CD105-FITC (R&D systems, USA), CD34-FITC (Becton, Dickinson and Company, USA), CD73-PE (Becton, Dickinson and Company, USA), CD45-PE (Thermo Fisher Scientific, USA), CD90-PE (Beckman Coulter, USA) at 4°C for 30minutes on the shaker.

    Article Title: Trophic and immunomodulatory effects of adipose tissue derived stem cells in a preclinical murine model of endometriosis
    Article Snippet: They were then incubated for 30 min at 25 °C with CD105-FITC, CD29-PE, Sca-1-APC, and CD45-PerCP (all from the Mouse Mesenchymal Stem Cell [MSC] Multi-Color Flow Kit, cat. no. FMC003; R&D Systems).

    Article Title: Dental pulp pluripotent-like stem cells (DPPSC), a new stem cell population with chromosomal stability and osteogenic capacity for biomaterials evaluation
    Article Snippet: The following fluorochrome labelled monoclonal antibodies were used: CD105-FITC (R&D Systems), CD29-PE (R&D Systems), CD146-FITC (BD Pharmingen), CD45-PE (BD Pharmingen), NANOG-FITC and OCT3/4-FITC (R&D Systems).

    Article Title: Deletion of RBPJK in Mesenchymal Stem Cells Enhances Osteogenic Activity by Up-Regulation of BMP Signaling.
    Article Snippet: Flow cytometry analysis MSC phenotype was evaluated after 2 weeks’ expansion by the expression of CD34-APC (BD Biosciences Pharmingen, San Diego, CA), CD45-FITC (BD Biosciences Pharmingen, San Diego, CA), CD90–PE (Dako Cytomation Denmark A/S, Glostrup, Denmark), CD73-PE (BD Biosciences Pharmingen) and CD105-FITC (RD Systems, Minneapolis, MN).

    Article Title: Overexpression of MiR-183/96/182 Triggers Retina-Like Fate in Human Bone Marrow-Derived Mesenchymal Stem Cells (hBMSCs) in Culture
    Article Snippet: Briefly, the cells were dissociated with trypsin/EDTA; then, cell suspensions were stained using various antibodies against MSC markers including CD105-FITC (R&D Systems), CD90-PE (Dako), CD73-PE (Abcam), CD45-FITC (Dako), and CD34-PE (Biosciences) and secondary goat antimouse IgG-PE.

    Article Title: Oleate Abrogates Palmitate-Induced Lipotoxicity and Proinflammatory Response in Human Bone Marrow-Derived Mesenchymal Stem Cells and Osteoblastic Cells.
    Article Snippet: Cells were stained with the following antibodies: CD34-PE, CD45-FITC and CD73-PE from BD Biosciences (San Jose, USA), CD90-APC, CD105-FITC, and ALP-APC from R&D Systems (Abingdon, United Kingdom) (34).

    Article Title: Autologous Matrix-Induced Chondrogenesis (AMIC) and AMIC Enhanced by Autologous Concentrated Bone Marrow Aspirate (BMAC) Allow for Stable Clinical and Functional Improvements at up to 9 Years Follow-Up: Results from a Randomized Controlled Study
    Article Snippet: The immunophenotype of cells cultured for two passages in human mesenchymal stem cells growth medium (MSCGM–Lonza, Verviers, Belgium) was analyzed by FACSCaliburTM (Becton-Dickinson, Franklin Lakes, NJ, USA) and CellQuestTM analysis software, after staining with the following conjugated antibodies: anti human CD45-PE, CD34-PE, CD31-PE, CD90-PE, CD73-PE, CD166-PE, CD44-PE (all from Becton Dickinson), and CD105-FITC (R&D System, Minneapolis, MN, USA).

    Article Title: Effect of inflammatory environment on equine bone marrow derived mesenchymal stem cells immunogenicity and immunomodulatory properties.
    Article Snippet: Mesenchymal stem cells (MSCs) are being investigated for the treatment of equine joint diseases because of their regenerative potential.. Recently, the focus mainly has addressed to their immunomodulatory capacities.. Inflammation plays a central role in joint pathologies, since the release of proinflammatory mediators to the synovial fluid (SF) leads to the activation of enzymatic degradation of the cartilage.

    FACS:

    Article Title: Interleukin-1β-induced matrix metalloproteinase-3 via ERK1/2 pathway to promote mesenchymal stem cell migration
    Article Snippet: Cell were then suspended 1*10 6 cells in 100 μl PBS and incubated with 1:20 dilution of conjugated antibodies CD105-FITC (R&D systems, USA), CD34-FITC (Becton, Dickinson and Company, USA), CD73-PE (Becton, Dickinson and Company, USA), CD45-PE (Thermo Fisher Scientific, USA), CD90-PE (Beckman Coulter, USA) at 4°C for 30minutes on the shaker.

    Article Title: Trophic and immunomodulatory effects of adipose tissue derived stem cells in a preclinical murine model of endometriosis
    Article Snippet: They were then incubated for 30 min at 25 °C with CD105-FITC, CD29-PE, Sca-1-APC, and CD45-PerCP (all from the Mouse Mesenchymal Stem Cell [MSC] Multi-Color Flow Kit, cat. no. FMC003; R&D Systems).

    Article Title: Dental pulp pluripotent-like stem cells (DPPSC), a new stem cell population with chromosomal stability and osteogenic capacity for biomaterials evaluation
    Article Snippet: The following fluorochrome labelled monoclonal antibodies were used: CD105-FITC (R&D Systems), CD29-PE (R&D Systems), CD146-FITC (BD Pharmingen), CD45-PE (BD Pharmingen), NANOG-FITC and OCT3/4-FITC (R&D Systems).

    Article Title: Deletion of RBPJK in Mesenchymal Stem Cells Enhances Osteogenic Activity by Up-Regulation of BMP Signaling.
    Article Snippet: Flow cytometry analysis MSC phenotype was evaluated after 2 weeks’ expansion by the expression of CD34-APC (BD Biosciences Pharmingen, San Diego, CA), CD45-FITC (BD Biosciences Pharmingen, San Diego, CA), CD90–PE (Dako Cytomation Denmark A/S, Glostrup, Denmark), CD73-PE (BD Biosciences Pharmingen) and CD105-FITC (RD Systems, Minneapolis, MN).

    Article Title: Overexpression of MiR-183/96/182 Triggers Retina-Like Fate in Human Bone Marrow-Derived Mesenchymal Stem Cells (hBMSCs) in Culture
    Article Snippet: Briefly, the cells were dissociated with trypsin/EDTA; then, cell suspensions were stained using various antibodies against MSC markers including CD105-FITC (R&D Systems), CD90-PE (Dako), CD73-PE (Abcam), CD45-FITC (Dako), and CD34-PE (Biosciences) and secondary goat antimouse IgG-PE.

    Article Title: Oleate Abrogates Palmitate-Induced Lipotoxicity and Proinflammatory Response in Human Bone Marrow-Derived Mesenchymal Stem Cells and Osteoblastic Cells.
    Article Snippet: Cells were stained with the following antibodies: CD34-PE, CD45-FITC and CD73-PE from BD Biosciences (San Jose, USA), CD90-APC, CD105-FITC, and ALP-APC from R&D Systems (Abingdon, United Kingdom) (34).

    Article Title: Autologous Matrix-Induced Chondrogenesis (AMIC) and AMIC Enhanced by Autologous Concentrated Bone Marrow Aspirate (BMAC) Allow for Stable Clinical and Functional Improvements at up to 9 Years Follow-Up: Results from a Randomized Controlled Study
    Article Snippet: The immunophenotype of cells cultured for two passages in human mesenchymal stem cells growth medium (MSCGM–Lonza, Verviers, Belgium) was analyzed by FACSCaliburTM (Becton-Dickinson, Franklin Lakes, NJ, USA) and CellQuestTM analysis software, after staining with the following conjugated antibodies: anti human CD45-PE, CD34-PE, CD31-PE, CD90-PE, CD73-PE, CD166-PE, CD44-PE (all from Becton Dickinson), and CD105-FITC (R&D System, Minneapolis, MN, USA).

    Article Title: Effect of inflammatory environment on equine bone marrow derived mesenchymal stem cells immunogenicity and immunomodulatory properties.
    Article Snippet: Mesenchymal stem cells (MSCs) are being investigated for the treatment of equine joint diseases because of their regenerative potential.. Recently, the focus mainly has addressed to their immunomodulatory capacities.. Inflammation plays a central role in joint pathologies, since the release of proinflammatory mediators to the synovial fluid (SF) leads to the activation of enzymatic degradation of the cartilage.



    Similar Products

    94
    Miltenyi Biotec cd105 fitc
    (a) Immunofluorescence staining showing expression of Vimentin (green) and <t>CD105</t> (red) in DPSC and SHED compared with HaCaT epithelial controls. (b) STRO-1 (green) immunostaining in SHED. Nuclei were counterstained with DAPI (blue). Scale bar = 100μm (c) Representative flow cytometry analyses demonstrating expression of mesenchymal stem cell markers (CD73, CD90, CD105, HLA-ABC) and absence of hematopoietic markers (CD34, CD45). All experiments were perfomed at passage 5 (d) Growth curves comparing cumulative population doublings of DPSC and SHED derived from four independent donors across serial passages. SHED displayed enhanced proliferative capacity and reduced donor-to-donor variability.
    Cd105 Fitc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd105-fitc/CD105+Antibody%2C+anti-human%2C+REAfinity/bio_rxiv__64898__2026__06__25__733625-69-8-9
    Average 94 stars, based on 1 article reviews
    cd105 fitc - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    94
    Elabscience Biotechnology cd45 apc
    (a) Immunofluorescence staining showing expression of Vimentin (green) and <t>CD105</t> (red) in DPSC and SHED compared with HaCaT epithelial controls. (b) STRO-1 (green) immunostaining in SHED. Nuclei were counterstained with DAPI (blue). Scale bar = 100μm (c) Representative flow cytometry analyses demonstrating expression of mesenchymal stem cell markers (CD73, CD90, CD105, HLA-ABC) and absence of hematopoietic markers (CD34, CD45). All experiments were perfomed at passage 5 (d) Growth curves comparing cumulative population doublings of DPSC and SHED derived from four independent donors across serial passages. SHED displayed enhanced proliferative capacity and reduced donor-to-donor variability.
    Cd45 Apc, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd105-fitc/FITC+Anti-Mouse+CD105+Antibody/pm41593745-63-18-27
    Average 94 stars, based on 1 article reviews
    cd45 apc - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    95
    R&D Systems anti cd105 fitc
    (a) Immunofluorescence staining showing expression of Vimentin (green) and <t>CD105</t> (red) in DPSC and SHED compared with HaCaT epithelial controls. (b) STRO-1 (green) immunostaining in SHED. Nuclei were counterstained with DAPI (blue). Scale bar = 100μm (c) Representative flow cytometry analyses demonstrating expression of mesenchymal stem cell markers (CD73, CD90, CD105, HLA-ABC) and absence of hematopoietic markers (CD34, CD45). All experiments were perfomed at passage 5 (d) Growth curves comparing cumulative population doublings of DPSC and SHED derived from four independent donors across serial passages. SHED displayed enhanced proliferative capacity and reduced donor-to-donor variability.
    Anti Cd105 Fitc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd105-fitc/FITC+Antibody/10__3390_slash_ijms262010017-179-30-31
    Average 95 stars, based on 1 article reviews
    anti cd105 fitc - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    94
    Bio-Rad human cd105 fitc bio rad formerly abd serotec
    (a) Immunofluorescence staining showing expression of Vimentin (green) and <t>CD105</t> (red) in DPSC and SHED compared with HaCaT epithelial controls. (b) STRO-1 (green) immunostaining in SHED. Nuclei were counterstained with DAPI (blue). Scale bar = 100μm (c) Representative flow cytometry analyses demonstrating expression of mesenchymal stem cell markers (CD73, CD90, CD105, HLA-ABC) and absence of hematopoietic markers (CD34, CD45). All experiments were perfomed at passage 5 (d) Growth curves comparing cumulative population doublings of DPSC and SHED derived from four independent donors across serial passages. SHED displayed enhanced proliferative capacity and reduced donor-to-donor variability.
    Human Cd105 Fitc Bio Rad Formerly Abd Serotec, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd105-fitc/Mouse+anti+Human+CD105/pmc12491781-108-3-6
    Average 94 stars, based on 1 article reviews
    human cd105 fitc bio rad formerly abd serotec - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    90
    STEMCELL Technologies Inc cd105-fitc 60039fi.1 antibody
    (a) Immunofluorescence staining showing expression of Vimentin (green) and <t>CD105</t> (red) in DPSC and SHED compared with HaCaT epithelial controls. (b) STRO-1 (green) immunostaining in SHED. Nuclei were counterstained with DAPI (blue). Scale bar = 100μm (c) Representative flow cytometry analyses demonstrating expression of mesenchymal stem cell markers (CD73, CD90, CD105, HLA-ABC) and absence of hematopoietic markers (CD34, CD45). All experiments were perfomed at passage 5 (d) Growth curves comparing cumulative population doublings of DPSC and SHED derived from four independent donors across serial passages. SHED displayed enhanced proliferative capacity and reduced donor-to-donor variability.
    Cd105 Fitc 60039fi.1 Antibody, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd105-fitc/anti+cd105/pmc11317610__pnas__2404146121__sapp-34-14-16
    Average 90 stars, based on 1 article reviews
    cd105-fitc 60039fi.1 antibody - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    93
    Sino Biological cat 10149 mm13 pe mouse anti cd34 fitc sinobiological
    (a) Immunofluorescence staining showing expression of Vimentin (green) and <t>CD105</t> (red) in DPSC and SHED compared with HaCaT epithelial controls. (b) STRO-1 (green) immunostaining in SHED. Nuclei were counterstained with DAPI (blue). Scale bar = 100μm (c) Representative flow cytometry analyses demonstrating expression of mesenchymal stem cell markers (CD73, CD90, CD105, HLA-ABC) and absence of hematopoietic markers (CD34, CD45). All experiments were perfomed at passage 5 (d) Growth curves comparing cumulative population doublings of DPSC and SHED derived from four independent donors across serial passages. SHED displayed enhanced proliferative capacity and reduced donor-to-donor variability.
    Cat 10149 Mm13 Pe Mouse Anti Cd34 Fitc Sinobiological, supplied by Sino Biological, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd105-fitc/Endoglin+%2F+CD105+Antibody%2C+Mouse+MAb/pm40570373-240-146-150
    Average 93 stars, based on 1 article reviews
    cat 10149 mm13 pe mouse anti cd34 fitc sinobiological - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    90
    Thermo Fisher antibodies against cd73 apc, cd105 pe, cd45 fitc, and cd34 apc
    Characterization of IFN‐γ‐iMSCs and IFN‐γ‐iMSC‐EVs. (a) Flow cytometry analysis of IFN‐γ‐iMSCs. The reactivities of IFN‐γ‐iMSCs against positive (CD105, CD73 and CD90) or negative (CD45, CD31 and <t>CD34)</t> markers of MSCs were evaluated. (b) Representative image of IDO1 protein expression in iMSCs and IFN‐γ‐iMSCs by immunocytochemistry analysis. Green and blue denote cells stained with anti‐IDO1 antibody and DAPI, respectively. (c) Immunoblot analysis of IDO1 protein levels in iMSCs and IFN‐γ‐iMSCs. n = 3. Data are presented as mean ± SE. ** p < 0.01 versus Control. (d) Scheme of the IFN‐γ‐iMSC‐EVs manufacturing. IFN‐γ‐iMSC‐EVs were isolated from the IFN‐γ‐iMSCs culture medium using ultracentrifugation. (e) Morphology of IFN‐γ‐iMSC‐EVs under cryo‐TEM. Scale bar = 200 nm. (f) Size distribution of IFN‐γ‐iMSC‐EVs shown by NTA. The average size is 134.6 nm. (g) Western blot analyses for markers of extracellular vesicles (CD9 and CD63) or cellular organelles (Cytochrome C and Histone H3) in IFN‐γ‐iMSCs and IFN‐γ‐iMSC‐EVs. (h) Expression analysis of EV markers (CD63 and CD81) in IFN‐γ‐iMSC‐EVs by flow cytometry.
    Antibodies Against Cd73 Apc, Cd105 Pe, Cd45 Fitc, And Cd34 Apc, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd105-fitc/cd29+antibody/pmc12183344-69-26-28
    Average 90 stars, based on 1 article reviews
    antibodies against cd73 apc, cd105 pe, cd45 fitc, and cd34 apc - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    (a) Immunofluorescence staining showing expression of Vimentin (green) and CD105 (red) in DPSC and SHED compared with HaCaT epithelial controls. (b) STRO-1 (green) immunostaining in SHED. Nuclei were counterstained with DAPI (blue). Scale bar = 100μm (c) Representative flow cytometry analyses demonstrating expression of mesenchymal stem cell markers (CD73, CD90, CD105, HLA-ABC) and absence of hematopoietic markers (CD34, CD45). All experiments were perfomed at passage 5 (d) Growth curves comparing cumulative population doublings of DPSC and SHED derived from four independent donors across serial passages. SHED displayed enhanced proliferative capacity and reduced donor-to-donor variability.

    Journal: bioRxiv

    Article Title: Human SHED-derived extracellular cues activate a specialized neuroprotective and regenerative program in developing retinal ganglion cells

    doi: 10.64898/2026.06.25.733625

    Figure Lengend Snippet: (a) Immunofluorescence staining showing expression of Vimentin (green) and CD105 (red) in DPSC and SHED compared with HaCaT epithelial controls. (b) STRO-1 (green) immunostaining in SHED. Nuclei were counterstained with DAPI (blue). Scale bar = 100μm (c) Representative flow cytometry analyses demonstrating expression of mesenchymal stem cell markers (CD73, CD90, CD105, HLA-ABC) and absence of hematopoietic markers (CD34, CD45). All experiments were perfomed at passage 5 (d) Growth curves comparing cumulative population doublings of DPSC and SHED derived from four independent donors across serial passages. SHED displayed enhanced proliferative capacity and reduced donor-to-donor variability.

    Article Snippet: Antibodies against the following human antigens were used: CD105-FITC (Miltenyi Biotect, Bergisch Gladbach, Germany, cat# 130-112-327, 1:50), CD90-FITC (Miltenyi Biotec, cat# 130-114-901, 1:50), CD44-VioBlue (Miltenyi Biotec, cat# 130-113-906, 1:50), CD73-APC (Miltenyi Biotec, cat# 130-111-909, 1:50), MSC Phenotyping Cocktail-PE (CD34, CD14, CD19, CD45, Miltenyi Biotec cat# 130-125-285, dilution according to the manufacturer’s instructions).

    Techniques: Immunofluorescence, Staining, Expressing, Immunostaining, Flow Cytometry, Derivative Assay

    Characterization of IFN‐γ‐iMSCs and IFN‐γ‐iMSC‐EVs. (a) Flow cytometry analysis of IFN‐γ‐iMSCs. The reactivities of IFN‐γ‐iMSCs against positive (CD105, CD73 and CD90) or negative (CD45, CD31 and CD34) markers of MSCs were evaluated. (b) Representative image of IDO1 protein expression in iMSCs and IFN‐γ‐iMSCs by immunocytochemistry analysis. Green and blue denote cells stained with anti‐IDO1 antibody and DAPI, respectively. (c) Immunoblot analysis of IDO1 protein levels in iMSCs and IFN‐γ‐iMSCs. n = 3. Data are presented as mean ± SE. ** p < 0.01 versus Control. (d) Scheme of the IFN‐γ‐iMSC‐EVs manufacturing. IFN‐γ‐iMSC‐EVs were isolated from the IFN‐γ‐iMSCs culture medium using ultracentrifugation. (e) Morphology of IFN‐γ‐iMSC‐EVs under cryo‐TEM. Scale bar = 200 nm. (f) Size distribution of IFN‐γ‐iMSC‐EVs shown by NTA. The average size is 134.6 nm. (g) Western blot analyses for markers of extracellular vesicles (CD9 and CD63) or cellular organelles (Cytochrome C and Histone H3) in IFN‐γ‐iMSCs and IFN‐γ‐iMSC‐EVs. (h) Expression analysis of EV markers (CD63 and CD81) in IFN‐γ‐iMSC‐EVs by flow cytometry.

    Journal: Journal of Extracellular Biology

    Article Title: iMSC‐Derived Extracellular Vesicles Improve Atopic Dermatitis by Augmenting Skin Barrier Integrity and Inhibiting Inflammation, Pruritus and Th2 Immune Responses

    doi: 10.1002/jex2.70067

    Figure Lengend Snippet: Characterization of IFN‐γ‐iMSCs and IFN‐γ‐iMSC‐EVs. (a) Flow cytometry analysis of IFN‐γ‐iMSCs. The reactivities of IFN‐γ‐iMSCs against positive (CD105, CD73 and CD90) or negative (CD45, CD31 and CD34) markers of MSCs were evaluated. (b) Representative image of IDO1 protein expression in iMSCs and IFN‐γ‐iMSCs by immunocytochemistry analysis. Green and blue denote cells stained with anti‐IDO1 antibody and DAPI, respectively. (c) Immunoblot analysis of IDO1 protein levels in iMSCs and IFN‐γ‐iMSCs. n = 3. Data are presented as mean ± SE. ** p < 0.01 versus Control. (d) Scheme of the IFN‐γ‐iMSC‐EVs manufacturing. IFN‐γ‐iMSC‐EVs were isolated from the IFN‐γ‐iMSCs culture medium using ultracentrifugation. (e) Morphology of IFN‐γ‐iMSC‐EVs under cryo‐TEM. Scale bar = 200 nm. (f) Size distribution of IFN‐γ‐iMSC‐EVs shown by NTA. The average size is 134.6 nm. (g) Western blot analyses for markers of extracellular vesicles (CD9 and CD63) or cellular organelles (Cytochrome C and Histone H3) in IFN‐γ‐iMSCs and IFN‐γ‐iMSC‐EVs. (h) Expression analysis of EV markers (CD63 and CD81) in IFN‐γ‐iMSC‐EVs by flow cytometry.

    Article Snippet: To verify the expression of typical MSC surface markers on IFN‐γ‐primed iMSCs (IFN‐γ‐iMSCs), they were stained with antibodies against CD73 APC, CD105 PE, CD45 FITC and CD34 APC (eBioscience, Waltham, MA, USA), as well as CD90 APC‐Cy7 (BioLegend, San Diego, CA, USA).

    Techniques: Flow Cytometry, Expressing, Immunocytochemistry, Staining, Western Blot, Control, Isolation